{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:33:27Z","timestamp":1789662807629,"version":"4.0.1"},"reference-count":148,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Frailty is a syndrome characterized by decreased reserves across multiple physiologic systems resulting in functional limitations and vulnerability to new stressors. Physical frailty develops over years in community-dwelling older adults but presents or worsens within days in the intensive care unit (ICU) because common mechanisms governing age-related physical frailty are often exacerbated by critical illness. The hallmark of physical frailty is a combined loss of muscle mass, force, and endurance. About one-third of ICU patients have frailty before hospitalization, which increases their risk for both short- and long-term disability and mortality. While there are several valid ways to measure clinical frailty in patients before or after an ICU admission, the mechanistic underpinnings of frailty in critically ill patients and ICU survivors have not been thoroughly investigated. Furthermore, therapeutic interventions to treat frailty during and after time in the ICU are lacking. In this narrative review, we examine studies that identify potential biological mechanisms underlying the development and propagation of physical frailty in both aging and critical illness (eg, inflammation, mitochondrial myopathy, and neuroendocrinopathy). We discuss specific aspects of these frailty mechanisms in older adults, critically ill patients, and ICU survivors that may represent therapeutic targets. Consistent with complexity underlying frailty, this syndrome is unlikely to result from an excess of a single harmful mediator or deficit of a single protective mediator. Rather, frailty occurs in the presence of an incompletely understood state of multisystem dysregulation. We further describe knowledge gaps that warrant clinical and translational research in frailty and critical care with an overall goal of developing effective frailty treatments in critically ill patients and ICU survivors.<\/jats:p>","DOI":"10.1213\/ane.0000000000004792","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T16:30:06Z","timestamp":1588955406000},"page":"1545-1555","source":"Crossref","is-referenced-by-count":30,"title":["Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets"],"prefix":"10.1213","volume":"130","author":[{"given":"Jonathan A.","family":"Paul","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Whittington","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Baldwin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.","volume":"59","author":"Fried","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty consensus: a call to action.","volume":"14","author":"Morley","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype.","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people.","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging.","volume":"1","author":"Mitnitski","year":"2001","journal-title":"ScientificWorldJournal"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/gerona\/61.3.262","article-title":"Phenotype of frailty: characterization in the women\u2019s health and aging studies.","volume":"61","author":"Bandeen-Roche","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R7-20230721","first-page":"674","article-title":"Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study.","volume":"40","author":"Le Maguet","year":"2014","journal-title":"Intensive Care Med"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1513\/AnnalsATS.201607-538OC","article-title":"Assessing the usefulness and validity of frailty markers in critically ill adults.","volume":"14","author":"Hope","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1513\/AnnalsATS.201612-1008OC","article-title":"Refining low physical activity measurement improves frailty assessment in advanced lung disease and survivors of critical illness.","volume":"14","author":"Baldwin","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rmed.2017.08.010","article-title":"Frailty and maximal exercise capacity in adult lung transplant candidates.","volume":"131","author":"Layton","year":"2017","journal-title":"Respir Med"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcrc.2013.12.019","article-title":"The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors.","volume":"29","author":"Baldwin","year":"2014","journal-title":"J Crit Care"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jamda.2007.07.012","article-title":"How should we grade frailty in nursing home patients?","volume":"8","author":"Rockwood","year":"2007","journal-title":"J Am Med Dir Assoc"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.201605-0939OC","article-title":"Frailty and subsequent disability and mortality among patients with critical illness.","volume":"196","author":"Brummel","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.1503\/cmaj.130639","article-title":"Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study.","volume":"186","author":"Bagshaw","year":"2014","journal-title":"CMAJ"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/CCM.0000000000000860","article-title":"Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study.","volume":"43","author":"Bagshaw","year":"2015","journal-title":"Crit Care Med"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-016-1338-x","article-title":"A prospective multicenter cohort study of frailty in younger critically ill patients.","volume":"20","author":"Bagshaw","year":"2016","journal-title":"Crit Care"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00134-017-4867-0","article-title":"The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis.","volume":"43","author":"Muscedere","year":"2017","journal-title":"Intensive Care Med"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/thoraxjnl-2015-208114","article-title":"Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms.","volume":"71","author":"Griffith","year":"2016","journal-title":"Thorax"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/rccm.201003-0326OC","article-title":"Survival in critical illness is associated with early activation of mitochondrial biogenesis.","volume":"182","author":"Carr\u00e9","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-015-0993-7","article-title":"Clinical review: intensive care unit acquired weakness.","volume":"19","author":"Hermans","year":"2015","journal-title":"Crit Care"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s13054-015-1160-x","article-title":"Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness.","volume":"19","author":"Jiroutkov\u00e1","year":"2015","journal-title":"Crit Care"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.chest.2016.03.045","article-title":"ICU-acquired weakness.","volume":"150","author":"Jolley","year":"2016","journal-title":"Chest"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.201607-1516CI","article-title":"On the neuroendocrinopathy of critical illness. Perspectives for feeding and novel treatments.","volume":"194","author":"Van den Berghe","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcrc.2017.11.017","article-title":"Pre-hospital frailty and hospital outcomes in adults with acute respiratory failure requiring mechanical ventilation.","volume":"44","author":"Hope","year":"2018","journal-title":"J Crit Care"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.chest.2018.03.007","article-title":"The association of frailty with post-ICU disability, nursing home admission, and mortality: a longitudinal study.","volume":"153","author":"Ferrante","year":"2018","journal-title":"Chest"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock.","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury.","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N Engl J Med"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1532-5415.2002.50157.x","article-title":"Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons.","volume":"50","author":"Reuben","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"M201","DOI":"10.1093\/gerona\/52A.4.M201","article-title":"The association of plasma IL-6 levels with functional disability in community-dwelling elderly.","volume":"52","author":"Cohen","year":"1997","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03324545","article-title":"Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.","volume":"16","author":"Leng","year":"2004","journal-title":"Aging Clin Exp Res"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/gerona\/59.3.M242","article-title":"Inflammatory markers and physical performance in older persons: the InCHIANTI study.","volume":"59","author":"Cesari","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1532-5415.2007.01186.x","article-title":"Inflammation and frailty in older women.","volume":"55","author":"Leng","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","article-title":"Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study.","volume":"57","author":"Visser","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/gerona\/glp097","article-title":"Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength.","volume":"64","author":"Schaap","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"526.e9","DOI":"10.1016\/j.amjmed.2005.10.049","article-title":"Inflammatory markers and loss of muscle mass (sarcopenia) and strength.","volume":"119","author":"Schaap","year":"2006","journal-title":"Am J Med"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1430001","article-title":"Novel insights into the neuroendocrinology of critical illness.","volume":"143","author":"Van den Berghe","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"R37-20230721","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1097\/00003246-199911000-00016","article-title":"Hypotestosteronemia in chronically critically ill men.","volume":"27","author":"Nierman","year":"1999","journal-title":"Crit Care Med"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00134-010-1840-6","article-title":"Hormonal status and ICU-acquired paresis in critically ill patients.","volume":"36","author":"Sharshar","year":"2010","journal-title":"Intensive Care Med"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/gerona\/gln026","article-title":"Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women\u2019s Health and Aging Studies.","volume":"64","author":"Cappola","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2013.278481","article-title":"Acute skeletal muscle wasting in critical illness.","volume":"310","author":"Puthucheary","year":"2013","journal-title":"JAMA"},{"key":"R41-20230721","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CCM.0000000000002058","article-title":"Point prevalence study of mobilization practices for acute respiratory failure patients in the United States.","volume":"45","author":"Jolley","year":"2017","journal-title":"Crit Care Med"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock.","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"key":"R43-20230721","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1164\/rccm.201512-2344OC","article-title":"Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay. A pilot study.","volume":"194","author":"Dos Santos","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-20230721","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/thoraxjnl-2017-211073","article-title":"Metabolic phenotype of skeletal muscle in early critical illness.","volume":"73","author":"Puthucheary","year":"2018","journal-title":"Thorax"},{"key":"R45-20230721","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.0501559102","article-title":"Decline in skeletal muscle mitochondrial function with aging in humans.","volume":"102","author":"Short","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R46-20230721","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1474-9726.2012.00844.x","article-title":"The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals.","volume":"11","author":"Joseph","year":"2012","journal-title":"Aging Cell"},{"key":"R47-20230721","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/gerona\/glu134","article-title":"Skeletal muscle mitochondrial function and fatigability in older adults.","volume":"70","author":"Santanasto","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R48-20230721","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/acel.12568","article-title":"Muscle strength mediates the relationship between mitochondrial energetics and walking performance.","volume":"16","author":"Zane","year":"2017","journal-title":"Aging Cell"},{"key":"R49-20230721","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00109-014-1233-3","article-title":"Association of mitochondrial DNA levels with frailty and all-cause mortality.","volume":"93","author":"Ashar","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"R50-20230721","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2017.12.015","article-title":"Aging, inflammation and the environment.","volume":"105","author":"Bektas","year":"2018","journal-title":"Exp Gerontol"},{"key":"R51-20230721","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1513\/AnnalsATS.201512-833FR","article-title":"Frailty in pulmonary and critical care medicine.","volume":"13","author":"Singer","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R52-20230721","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity.","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J Clin Invest"},{"key":"R53-20230721","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pharmthera.2012.05.006","article-title":"Imaging inflammation: molecular strategies to visualize key components of the inflammatory cascade, from initiation to resolution.","volume":"135","author":"Dorward","year":"2012","journal-title":"Pharmacol Ther"},{"key":"R54-20230721","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"R55-20230721","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system.","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"key":"R56-20230721","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation.","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"R57-20230721","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R58-20230721","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology.","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"R59-20230721","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine.","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"R60-20230721","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10.","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"R61-20230721","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J"},{"key":"R62-20230721","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","article-title":"Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.","volume":"177","author":"Yende","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R63-20230721","doi-asserted-by":"crossref","first-page":"e198686","DOI":"10.1001\/jamanetworkopen.2019.8686","article-title":"Long-term host immune response trajectories among hospitalized patients with sepsis.","volume":"2","author":"Yende","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R64-20230721","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins.","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J Immunol"},{"key":"R65-20230721","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"R66-20230721","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.exger.2009.05.005","article-title":"Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women\u2019s Health and Aging Studies I.","volume":"44","author":"Leng","year":"2009","journal-title":"Exp Gerontol"},{"key":"R67-20230721","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1532-5415.2008.01673.x","article-title":"T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults.","volume":"56","author":"De Fanis","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"R68-20230721","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/34814","article-title":"CCR5 is characteristic of Th1 lymphocytes.","volume":"391","author":"Loetscher","year":"1998","journal-title":"Nature"},{"key":"R69-20230721","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ageing\/afr047","article-title":"IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults.","volume":"40","author":"Leng","year":"2011","journal-title":"Age Ageing"},{"key":"R70-20230721","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cyto.2009.02.015","article-title":"Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty.","volume":"46","author":"Qu","year":"2009","journal-title":"Cytokine"},{"key":"R71-20230721","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198303103081002","article-title":"Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.","volume":"308","author":"Baracos","year":"1983","journal-title":"N Engl J Med"},{"key":"R72-20230721","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj2580493","article-title":"Effect of recombinant human tumour necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats.","volume":"258","author":"Charters","year":"1989","journal-title":"Biochem J"},{"key":"R73-20230721","first-page":"R659","article-title":"Cachectin\/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.","volume":"256","author":"Fong","year":"1989","journal-title":"Am J Physiol"},{"key":"R74-20230721","first-page":"2295","article-title":"Tumor necrosis factor inhibits human myogenesis in vitro.","volume":"8","author":"Miller","year":"1988","journal-title":"Mol Cell Biol"},{"key":"R75-20230721","first-page":"27","article-title":"Effect of tumor necrosis factor or interleukin-1 on muscle amino acid uptake and the role of glucocorticoids.","volume":"177","author":"Zamir","year":"1993","journal-title":"Surg Gynecol Obstet"},{"key":"R76-20230721","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.","volume":"343","author":"Bathon","year":"2000","journal-title":"N Engl J Med"},{"key":"R77-20230721","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1316133","article-title":"Sustained remission with etanercept tapering in early rheumatoid arthritis.","volume":"371","author":"Emery","year":"2014","journal-title":"N Engl J Med"},{"key":"R78-20230721","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R79-20230721","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"R80-20230721","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.283.13.1723","article-title":"E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators.","volume":"283","author":"Angus","year":"2000","journal-title":"JAMA"},{"key":"R81-20230721","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00003246-200104000-00015","article-title":"Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES Study.","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit Care Med"},{"key":"R82-20230721","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00003246-199605000-00003","article-title":"Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.","volume":"24","author":"Reinhart","year":"1996","journal-title":"Crit Care Med"},{"key":"R83-20230721","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"R84-20230721","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcsm.12051","article-title":"Biomarkers for physical frailty and sarcopenia: state of the science and future developments.","volume":"6","author":"Calvani","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R85-20230721","doi-asserted-by":"crossref","first-page":"18050","DOI":"10.1038\/s41598-018-36679-4","article-title":"Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.","volume":"8","author":"Norris","year":"2018","journal-title":"Sci Rep"},{"key":"R86-20230721","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/jgs.12029","article-title":"Statins, angiotensin-converting enzyme inhibitors, and physical performance in older women.","volume":"60","author":"Gray","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"R87-20230721","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome.","volume":"371","author":"McAuley","year":"2014","journal-title":"N Engl J Med"},{"key":"R88-20230721","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome.","volume":"370","author":"Truwit","year":"2014","journal-title":"N Engl J Med"},{"key":"R89-20230721","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.2013.280031","article-title":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial.","volume":"310","author":"Papazian","year":"2013","journal-title":"JAMA"},{"key":"R90-20230721","doi-asserted-by":"crossref","first-page":"e82775","DOI":"10.1371\/journal.pone.0082775","article-title":"The effect of statins on mortality in septic patients: a meta-analysis of randomized controlled trials.","volume":"8","author":"Pasin","year":"2013","journal-title":"PLoS One"},{"key":"R91-20230721","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/thoraxjnl-2015-208017","article-title":"One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.","volume":"71","author":"Dinglas","year":"2016","journal-title":"Thorax"},{"key":"R92-20230721","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-2600(16)00005-9","article-title":"Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.","volume":"4","author":"Needham","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R93-20230721","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2018.01.012","article-title":"A mitochondrial health index sensitive to mood and caregiving stress.","volume":"84","author":"Picard","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"pt 1","key":"R94-20230721","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1469-7793.2000.t01-1-00203.x","article-title":"Oxidative capacity and ageing in human muscle.","volume":"526","author":"Conley","year":"2000","journal-title":"J Physiol"},{"key":"R95-20230721","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0000000000002705","article-title":"A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.","volume":"86","author":"Davis","year":"2016","journal-title":"Neurology"},{"key":"R96-20230721","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/thoraxjnl-2019-213621","article-title":"Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure.","volume":"74","author":"Rosenberg","year":"2019","journal-title":"Thorax"},{"key":"R97-20230721","doi-asserted-by":"crossref","first-page":"e11069","DOI":"10.1371\/journal.pone.0011069","article-title":"Polymorphisms in the mitochondrial DNA control region and frailty in older adults.","volume":"5","author":"Moore","year":"2010","journal-title":"PLoS One"},{"key":"R98-20230721","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.exger.2012.03.004","article-title":"The effects of aging, physical training, and a single bout of exercise on mitochondrial protein expression in human skeletal muscle.","volume":"47","author":"Bori","year":"2012","journal-title":"Exp Gerontol"},{"key":"R99-20230721","doi-asserted-by":"crossref","first-page":"467S","DOI":"10.3945\/ajcn.2008.26717D","article-title":"Muscle mitochondrial changes with aging and exercise.","volume":"89","author":"Lanza","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R100-20230721","doi-asserted-by":"crossref","first-page":"194821","DOI":"10.1155\/2012\/194821","article-title":"Skeletal muscle mitochondria and aging: a review.","volume":"2012","author":"Peterson","year":"2012","journal-title":"J Aging Res"},{"key":"R101-20230721","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(09)60658-9","article-title":"Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.","volume":"373","author":"Schweickert","year":"2009","journal-title":"Lancet"},{"key":"R102-20230721","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/cc12835","article-title":"Exercise rehabilitation for patients with critical illness: a randomized controlled trial with 12 months of follow-up.","volume":"17","author":"Denehy","year":"2013","journal-title":"Crit Care"},{"key":"R103-20230721","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamainternmed.2015.0822","article-title":"Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge: the RECOVER randomized clinical trial.","volume":"175","author":"Walsh","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R104-20230721","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/rccm.201505-1039OC","article-title":"A randomized trial of an intensive physical therapy program for patients with acute respiratory failure.","volume":"193","author":"Moss","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R105-20230721","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcrc.2014.09.014","article-title":"Neuromuscular electrical stimulation in mechanically ventilated patients: a randomized, sham-controlled pilot trial with blinded outcome assessment.","volume":"30","author":"Kho","year":"2015","journal-title":"J Crit Care"},{"key":"R106-20230721","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jcrc.2014.06.024","article-title":"Feasibility of neuromuscular electrical stimulation in critically ill patients.","volume":"29","author":"Segers","year":"2014","journal-title":"J Crit Care"},{"key":"R107-20230721","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.2018.9592","article-title":"Effect of in-bed leg cycling and electrical stimulation of the quadriceps on global muscle strength in critically ill adults: a randomized clinical trial.","volume":"320","author":"Fossat","year":"2018","journal-title":"JAMA"},{"key":"R108-20230721","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies.","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R109-20230721","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.0709144105","article-title":"Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors.","volume":"105","author":"Haidet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R110-20230721","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2174\/13816128113196660062","article-title":"Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.","volume":"20","author":"Maggio","year":"2014","journal-title":"Curr Pharm Des"},{"key":"R111-20230721","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2265.2005.02355.x","article-title":"Endocrine and inflammatory markers as predictors of frailty.","volume":"63","author":"Puts","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R112-20230721","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/archinte.167.20.2249","article-title":"Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study.","volume":"167","author":"Maggio","year":"2007","journal-title":"Arch Intern Med"},{"key":"R113-20230721","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men.","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"R114-20230721","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jcsm.12291","article-title":"Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.","volume":"9","author":"Skinner","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R115-20230721","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","article-title":"Systematic review: the safety and efficacy of growth hormone in the healthy elderly.","volume":"146","author":"Liu","year":"2007","journal-title":"Ann Intern Med"},{"key":"R116-20230721","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa054629","article-title":"DHEA in elderly women and DHEA or testosterone in elderly men.","volume":"355","author":"Nair","year":"2006","journal-title":"N Engl J Med"},{"key":"R117-20230721","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1532-5415.2011.03410.x","article-title":"Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review.","volume":"59","author":"Baker","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"R118-20230721","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/gerona\/63.7.696","article-title":"Is research on hormones and aging finished? No! Just started!","volume":"63","author":"Cappola","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R119-20230721","first-page":"590","article-title":"The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.","volume":"82","author":"Van den Berghe","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R120-20230721","first-page":"309","article-title":"Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.","volume":"83","author":"Van den Berghe","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R121-20230721","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.2002.01255.x","article-title":"The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.","volume":"56","author":"Van den Berghe","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R122-20230721","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/rccm.201002-0210CI","article-title":"Chronic critical illness.","volume":"182","author":"Nelson","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R123-20230721","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ccc.2016.12.001","article-title":"Persistent inflammation, immunosuppression and catabolism syndrome.","volume":"33","author":"Mira","year":"2017","journal-title":"Crit Care Clin"},{"key":"R124-20230721","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults.","volume":"341","author":"Takala","year":"1999","journal-title":"N Engl J Med"},{"key":"R125-20230721","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EC-19-0318","article-title":"Anterior pituitary function in critical illness.","volume":"8","author":"T\u00e9blick","year":"2019","journal-title":"Endocr Connect"},{"key":"R126-20230721","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1165\/rcmb.2014-0226TR","article-title":"Ghrelin in critical illness.","volume":"53","author":"Narula","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R127-20230721","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/CCM.0000000000002625","article-title":"Is there a role for enterohormones in the gastroparesis of critically ill patients?","volume":"45","author":"Santacruz","year":"2017","journal-title":"Crit Care Med"},{"key":"R128-20230721","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/15287394.2019.1654639","article-title":"Serum cortisol but not oxidative stress biomarkers are related to frailty: results of a cross-sectional study in Spanish older adults.","volume":"82","author":"Marcos-P\u00e9rez","year":"2019","journal-title":"J Toxicol Environ Health A"},{"key":"R129-20230721","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness.","volume":"368","author":"Boonen","year":"2013","journal-title":"N Engl J Med"},{"key":"R130-20230721","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cphy.c170022","article-title":"Adrenocortical stress response during the course of critical illness.","volume":"8","author":"Peeters","year":"2017","journal-title":"Compr Physiol"},{"key":"R131-20230721","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00134-018-5366-7","article-title":"Adrenocortical function during prolonged critical illness and beyond: a prospective observational study.","volume":"44","author":"Peeters","year":"2018","journal-title":"Intensive Care Med"},{"key":"R132-20230721","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/CCM.0000000000001633","article-title":"Glucocorticoid sensitivity is highly variable in critically ill patients with septic shock and is associated with disease severity.","volume":"44","author":"Cohen","year":"2016","journal-title":"Crit Care Med"},{"key":"R133-20230721","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.","volume":"354","author":"Steinberg","year":"2006","journal-title":"N Engl J Med"},{"key":"R134-20230721","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0034-1396893","article-title":"Focus on vitamin D and the adrenal gland.","volume":"47","author":"Muscogiuri","year":"2015","journal-title":"Horm Metab Res"},{"key":"R135-20230721","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0169-328X(95)00314-I","article-title":"Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells.","volume":"36","author":"Puchacz","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"R136-20230721","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/gerona\/gln007","article-title":"Association of low vitamin D levels with the frailty syndrome in men and women.","volume":"64","author":"Shardell","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R137-20230721","doi-asserted-by":"crossref","first-page":"e014619","DOI":"10.1136\/bmjopen-2016-014619","article-title":"The effect of combined resistance exercise training and vitamin D3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis.","volume":"7","author":"Antoniak","year":"2017","journal-title":"BMJ Open"},{"key":"R138-20230721","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-018-2185-8","article-title":"Vitamin D deficiency and supplementation in critical illness-the known knowns and known unknowns.","volume":"22","author":"Nair","year":"2018","journal-title":"Crit Care"},{"key":"R139-20230721","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1911124","article-title":"Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients.","volume":"381","author":"Ginde","year":"2019","journal-title":"N Engl J Med"},{"key":"R140-20230721","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0025-6196(11)60963-4","article-title":"Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials.","volume":"82","author":"Bolo\u00f1a","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"R141-20230721","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2007.51","article-title":"Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.","volume":"299","author":"Emmelot-Vonk","year":"2008","journal-title":"JAMA"},{"key":"R142-20230721","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamapsychiatry.2018.2734","article-title":"Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis.","volume":"76","author":"Walther","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"R143-20230721","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4158\/EP14003.OR","article-title":"Low testosterone levels are frequent in patients with acute respiratory failure and are associated with poor outcomes.","volume":"20","author":"Almoosa","year":"2014","journal-title":"Endocr Pract"},{"key":"R144-20230721","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1164\/rccm.201510-2023OC","article-title":"Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study.","volume":"194","author":"Ou","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R145-20230721","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/CCM.0000000000001824","article-title":"Risk of recurrence after surviving severe sepsis: a matched cohort study.","volume":"44","author":"Shen","year":"2016","journal-title":"Crit Care Med"},{"key":"R146-20230721","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201307-1321OC","article-title":"Risk of cardiovascular events in survivors of severe sepsis.","volume":"189","author":"Yende","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R147-20230721","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/SLA.0000000000001844","article-title":"Reversal of growth arrest with the combined administration of oxandrolone and propranolol in severely burned children.","volume":"264","author":"Herndon","year":"2016","journal-title":"Ann Surg"},{"key":"R148-20230721","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.BCR.0000202620.55751.4F","article-title":"Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial.","volume":"27","author":"Wolf","year":"2006","journal-title":"J Burn Care Res"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:25:57Z","timestamp":1786112757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":148,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004792","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}